| IMMUNIC INC. DL-,0001 |
| USA |
| Gesundheit |
| US4525EP1011 / A2PHD4 |
| 10VA (Frankfurt) / IMUX (NASDAQ) |
| FRA:10VA, ETR:10VA, 10VA:GR, NASDAQ:IMUX |
| - |
| https://www.immunic-thera.. |
|
Immunic, Inc. is a clinical-stage biopharmaceutical company focused on developing oral therapies for chronic inflammatory and autoimmune diseases. Headquartered in New York, United States, the company concentrates on small-molecule drugs designed to ..
>Volltext.. |
| 163.21 Mio. EUR |
| 2.24 Mio. EUR |
| - |
| -94.64 Mio. EUR |
| -90.15 Mio. EUR |
| -5.22 EUR |
| 0.36 Mio. EUR |
| 161.34 Mio. EUR |
| -70.31 Mio. EUR |
| 4.86 |
| - |
| -8.19% |
| - |
| - |
| - |
| - |
| IMMUNIC |
| 15.06.26 |
|